Drugnews 藥時事
Sourced, dated facts on biotech and pharma companies, deals and Taiwan biotech filings.
我該用這個嗎
品質與安全性
根據工具定義與協定合規性的自動化分析。
上下文成本
這是每次將伺服器的工具載入模型上下文時所消耗的約略 token 數量。數量越高，可用於其他工作的注意力就越少。
安裝
一鍵安裝
將以下內容加入你的 `claude_desktop_config.json` 檔案：
{
"mcpServers": {
"mcp": {
"url": "https://drugnews.com.tw/mcp"
}
}
}遠端端點
https://drugnews.com.tw/mcpstreamable-http它能做什麼
工具清單
工具（13）
🟢search_articles(query, limit, lang)
Full-text search over Drugnews｜藥時事 biotech and pharma business analysis (Traditional Chinese and English). Returns title, canonical URL, date, summary, key points and the .json / .md twins. Use Chinese or English company, drug or topic names.
輸入結構描述
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Keywords: company, drug, indication, deal, topic (e.g. 'Celltrion 生物相似藥', 'Anktiva bladder cancer')"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 20,
"default": 8
},
"lang": {
"type": "string",
"enum": [
"zh-Hant",
"en",
"any"
],
"default": "any"
}
},
"required": [
"query"
]
}🟢get_article(url)
Returns the machine-readable twin of one article: title, date, summary, key points (three quotable conclusions), fact table (value + source + as-of date), references, section headings and image URLs. Pass the article URL, or '<date>-<slug>' (e.g. 2026-10-18-immunitybio-anktiva-papillary-early-approval).
輸入結構描述
{
"type": "object",
"properties": {
"url": {
"type": "string",
"description": "Article URL or <date>-<slug>"
}
},
"required": [
"url"
]
}🟢get_facts(query, limit)
Returns dated, sourced facts (number, unit, as-of date, source URL, article URL) collected across Drugnews articles that match the query. Best for 'what are the numbers on X' questions; every fact carries the public source it came from.
輸入結構描述
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Company, drug or topic (e.g. 'ImmunityBio', 'UroGen', 'CDMO 台康')"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 60,
"default": 25
}
},
"required": [
"query"
]
}⚪latest_articles(limit, lang)
The newest Drugnews articles with title, URL, date, summary and key points. Default: 10 Chinese articles.
輸入結構描述
{
"type": "object",
"properties": {
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 30,
"default": 10
},
"lang": {
"type": "string",
"enum": [
"zh-Hant",
"en",
"any"
],
"default": "zh-Hant"
}
}
}🟢get_company(name)
Structured profile of a biotech / pharma / tech company: verified facts with sources and dates (products, milestones, capacity, financials, partnerships), plus the company's own responses to negative events. Data is provided by the company and verified by Drugnews on verified_at; negative events are kept and the company's response is listed alongside. Use the company name, alias or ticker. Profiles state whether the company provided them or Drugnews compiled them from public filings.
輸入結構描述
{
"type": "object",
"properties": {
"name": {
"type": "string",
"description": "Company name (Chinese or English), alias or stock ticker, e.g. '台康生技', 'EirGenix', '6589'"
}
},
"required": [
"name"
]
}🟢search_partners(query, publisher, limit)
Headlines from Drugnews partner publications (e.g. 環球生技) with link, date, a one-line Drugnews summary and sourced facts. Full text stays on the publisher's site; cite the publisher and link.
輸入結構描述
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Keywords: company, drug, topic"
},
"publisher": {
"type": "string",
"description": "Limit to one publisher name (optional)"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 20,
"default": 8
}
},
"required": [
"query"
]
}🟡latest_filings(company, query, days, limit)
Material announcements (重大訊息) of Taiwan-listed, OTC and emerging biotech/medical companies, collected hourly from the Market Observation Post System (公開資訊觀測站): subject, full text, clause, fact date, time. Primary source, no interpretation. Filter by company (name or ticker), keywords and days. Cite the company, date and subject (cite_as).
輸入結構描述
{
"type": "object",
"properties": {
"company": {
"type": "string",
"description": "Company name or ticker, e.g. '台康生技' or '6589' (optional)"
},
"query": {
"type": "string",
"description": "Keywords in subject or text, e.g. '授權', 'FDA', '臨床' (optional)"
},
"days": {
"type": "integer",
"minimum": 1,
"maximum": 90,
"default": 7
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}⚪biotech_movers(date, direction, limit)
Daily closing price moves of Taiwan-listed, OTC and emerging biotech and medical stocks, each linked to same-day material announcements and related Drugnews articles. Official exchange data; facts only.
輸入結構描述
{
"type": "object",
"properties": {
"date": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Trading date in YYYY-MM-DD; omit for the latest board."
},
"direction": {
"type": "string",
"enum": [
"up",
"down",
"all"
],
"default": "all"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 50,
"default": 15
}
}
}🟢search_pipeline(query, phase, limit)
Search Taiwan biotech pipelines by indication, drug name or phase; every row links to its primary source.
輸入結構描述
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Indication, drug name or asset code (optional)"
},
"phase": {
"type": "string",
"enum": [
"preclinical",
"phase1",
"phase2",
"phase3",
"filed",
"approved"
]
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}⚪upcoming_catalysts(from, to, limit)
Dated upcoming events (FDA decisions, trial readouts, filings) for Taiwan biotech companies, sorted by date, each with its primary source.
輸入結構描述
{
"type": "object",
"properties": {
"from": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Inclusive start date in YYYY-MM-DD; defaults to today."
},
"to": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Inclusive end date in YYYY-MM-DD; defaults to 18 months after today."
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 30
}
}
}🟢search_deals(query, limit)
Licensing and partnership deals of Taiwan biotech companies with upfront, milestone and royalty terms exactly as disclosed, each with sources.
輸入結構描述
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Company or partner name (optional)"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}🟢get_topic_table(slug)
Returns the Chinese and English topic table JSON, with company, ticker, asset, indication, dated verified stage, original source quotation, and disclosed catalyst. Every row retains primary-source URLs and dates.
輸入結構描述
{
"type": "object",
"properties": {
"slug": {
"type": "string",
"enum": [
"adc",
"biosimilars-cdmo",
"bispecific-io",
"cell-therapy",
"cns",
"gene-nucleic-acid",
"glp1-obesity",
"improved-new-drugs",
"ophthalmology",
"radiopharmaceuticals",
"vaccines"
]
}
},
"required": [
"slug"
],
"additionalProperties": false
}🟢get_answer_card(id)
Returns one Chinese or English question and direct answer, dated facts, primary-source URLs, short original quotations, and the limits of the reviewed public documents.
輸入結構描述
{
"type": "object",
"properties": {
"id": {
"type": "string",
"enum": [
"E02",
"E05",
"E06",
"E10",
"E13",
"E14",
"E17",
"E19",
"Z02",
"Z05",
"Z06",
"Z10",
"Z13",
"Z14",
"Z17",
"Z19"
]
}
},
"required": [
"id"
],
"additionalProperties": false
}社群
證據